Many veterans of the 1991 Persian Gulf War (GW) returned with a chronic multisymptom illness that has been termed Gulf War Illness (GWI). Previous GWI studies have suggested that exposure to acetylcholinesterase inhibitors (AChEIs) in theater, such as sarin and/or pesticides, may have contributed to the symptomatology of GWI. Additionally, concomitant high physiological stress experienced during the war may have contributed to the initiation of the GWI phenotype. Although inhibition of AChE leading to accumulation of acetylcholine (ACh) will activate the cholinergic anti-inflammatory pathway, the signature symptomatology of GWI has been shown to be associated with neuroinflammation. To investigate the relationship between ACh and neuroinflammation in discrete brain regions, we used our previously established mouse model of GWI, which combines an exposure to a high physiological stress mimic, corticosterone (CORT), with GW-relevant AChEIs. The AChEIs used in this study were diisopropyl fluorophosphate (DFP), chlorpyrifos oxon (CPO), and physostigmine (PHY). After AChEI exposure, ACh concentrations for cortex (CTX), hippocampus (HIP), and striatum (STR) were determined using hydrophilic interaction liquid chromatography with ultraperformance liquid chromatography-tandem-mass spectrometry (MS/MS). CORT pretreatment ameliorated the DFP-induced ACh increase in HIP and STR, but not CTX. CORT pretreatment did not significantly alter ACh levels for CPO and PHY. Further analysis of STR neuroinflammatory biomarkers revealed an exacerbated CORT þ AChEI response, which does not correspond to measured brain ACh. By utilizing this new analytical method for discrete brain region analysis of ACh, this work suggests the exacerbated neuroinflammatory effects in our mouse model of GWI are not driven by the accumulation of brain region-specific ACh.
unknown, but it has been suggested that in theater exposures to acetylcholinesterase inhibitors (AChEIs), such as the nerve agent sarin, pesticides (eg, chlorpyrifos [CPF] and dichlorvos), and oral nerve agent prophylactics, such as pyridostigmine bromide (PB), may have contributed to the initiation of the illness (Locker et al., 2017; O'Callaghan et al., 2015; RAC, 2014) . Additionally, concomitant high physiological stress in theater may have contributed to the etiology of GWI (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015) .
The similarity between the symptomatology of GWI and sickness behavior is suggestive of an underlying neuroinflammatory condition (Dantzer et al., 2008; Godbout et al., 2005) and also is known to be associated with animal models of GWI (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015) . Despite the relationship of neuroinflammation to GWI, and the suggestion that AChEIs play a role in GWI etiology, the underlying cause(s) of GWI have yet to be determined. Several animal studies have shown that irreversible AChEIs, such as soman, sarin, dichlorvos, and diisopropyl fluorophosphate (DFP), as expected, cause a dramatic increase in brain acetylcholine (ACh) levels, specifically in the striatum (STR), hippocampus (HIP), and cortex (CTX) shortly after exposure (Flynn and Wecker, 1986; Russell et al., 1981; Stavinoha et al., 1976) . Similar results have been reported for reversible AChEIs, such as physostigmine (PHY) (Hallak and Giacobini, 1986) . Exposures to soman (Johnson and Kan, 2010) , sarin (Henderson et al., 2002) , the sarin surrogate, DFP (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015) , and CPF (Locker et al., 2017) also have been shown to increase proinflammatory mediators in brain hours after AChEI exposure, suggesting a potential role of AChEIs in acute (6-48-h postAChEI exposure) neuroinflammation. In animal models of GWI that incorporate chronic corticosterone (CORT) exposure prior to AChEI exposures to mimic concomitant high physiological stress likely experienced by service members in theater, a markedly exacerbated neuroinflammatory response occurs for CORT plus irreversible AChEIs when compared with irreversible AChEIs alone (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015) . In contrast, inhibition of brain AChE activity by irreversible AChEIs appears to be blunted in whole brain by prior CORT exposure (CORT priming), suggesting an AChEindependent mechanism for AChEI-related neuroinflammation (Locker et al., 2017) .
Although our previous study indicated a CORT-effect on whole brain AChE activity (Locker et al., 2017) , it is unclear how this may affect brain region-specific ACh accumulation. Several studies have indicated the potential for glucocorticoid exposure to affect AChE enzyme expression levels in muscle and liver (Askanas et al., 1992; Brank et al., 1998; Weber et al., 1999) . Interestingly, Wuppen et al. (2010) found that combined exposure to CORT and PHY increased AChE expression in the brain. Thus, measurement of ACh in discrete brain regions following exposure to our model of GWI may offer additional insight as to the role of ACh accumulation in GWI.
In order to elucidate the potential relationship between brain ACh and neuroinflammation, or lack thereof, in GWI etiology, this study combined focused microwave irradiation (O'Callaghan and Sriram, 2004) and hydrophilic interaction liquid chromatography (HILIC)-mass spectrometry (MS/MS) to measure ACh concentrations in discrete brain regions of a mouse model of GWI. Here, in concurrence with our previous study (Locker et al., 2017) , several AChEIs were employed, including: DFP, an irreversible AChEI and sarin surrogate; CPF oxon (CPO), the active metabolite of CPF, an irreversible AChEI insecticide used in theater; and PHY, a reversible AChEI that has the ability to cross the blood brain barrier and is similar to PB (Grauer et al., 2000) , which was used as a prophylactic against nerve agents in theater. ACh concentrations were elevated after AChEI exposure alone, but CORT þ DFP exposure ameliorated AChEI-induced ACh increase in STR and HIP. There was no mixture ameliorating effect on ACh for CPO or PHY. As changes in ACh were most pronounced in the STR, we investigated the neuroinflammatory response to these conditions in this brain area; CORT þ DFP and CORT þ CPO resulted in exacerbated neuroinflammatory responses when compared with AChEI alone, whereas CORT þ PHY exhibited minimal effects. These results suggest an AChE-independent action of DFP and CPO when primed with CORT that is driving the exacerbated neuroinflammatory response in this mouse model of GWI.
MATERIALS AND METHODS
Materials DFP, PHY, and ethanol (EtOH) were purchased from SigmaAldrich Co. (St Louis, Missouri), CPO was purchased from Chem Service, Inc. (West Chester, Pennsylvania), and CORT was purchased from Steraloids Inc. (Newport, Rhode Island). Ultraperformance liquid chromatography-mass spectrometry (UPLC-MS/MS) standards, ACh chloride and acetylcholine-1,1,2,2-d 4 chloride (ACh-d 4 ) was purchased from Sigma-Aldrich Co. and CDN Isotopes Inc (Pointe-Claire, Quebec, Canada), respectively. HPLC grade reagents were used for all UPLC-MS analyses.
Animals
Adult male C57Bl/6J mice (n ¼ 5 or 7/group; 8-12 weeks of age) were purchased from Jackson Laboratory (Bar Harbor, Maine). All mouse procedures were performed according to protocols approved by the Institutional Animal Care and Use Committee of the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health and U.S. Army Medical Research and Material Command Animal Care and Use Review Office. The animal care program was accredited by AAALAC, International. Upon arrival, mice were individually housed in a temperature-(21 C 6 1 C) and humidity-controlled (50% 6 10%) colony room maintained under filtered positivepressure ventilation on a 12-h light (06:00 EDT)/12-h dark cycle (18:00 EDT). Mice were individually housed in 12.1 Â 5 Â 5 in (30.7 Â 12.7 Â 12.7 cm) plastic cages with hardwood bedding (Teklad sani-chips 7090, Envigo, Indianapolis, Indiana) at a depth of 1-2 cm. Throughout the study, mice were singly housed and given ad libitum access to food (Harlan 7913 irradiated NIH-31 modified 6% rodent chow) and water.
Dosing
Mice (n ¼ 5) were exposed to CORT and AChEIs as previously described (Locker et al., 2017) . Briefly, intraperitoneal (i.p.) injections of saline (0.9%), peanut oil (CPO vehicle), CPO (8 mg/kg,) DFP (4 mg/kg), or PHY (0.5 mg/kg) were administered in the morning and returned to their home cage. CORT was given in the drinking water (400 mg/l in 1.2% EtOH) for 4 days prior to AChEI or vehicle exposure. CPO, the active, AChE inhibiting metabolite of CPF, was given in place of CPF to avoid variability related to interanimal differences in the bioactivation of CPF to CPO in vivo (Cole et al., 2005; Jiang et al., 2010 Jiang et al., , 2012 . For ACh quantification, mice were sacrificed at 30 min (DFP, CPO, and PHY groups) and 45 min (PHY groups) post-AChEI or vehicle exposure by focused microwave irradiation (Muromachi Microwave Fixation Applicator, model TMW-4012C, Tokyo, Japan; 6 kW 0.9s) to preserve in vivo steady state levels of ACh. For qPCR analyses, mice were sacrificed via decapitation at 6-h postexposure to AChEI or vehicle.
Brain Dissection and Preparation
After sacrifice via decapitation or focused-microwave irradiation, whole brains were immediately removed from the skull and the CTX, HIP, and STR were dissected free-hand with fine curved forceps on a thermoelectric cold plate (Model TCP-2; Aldrich Chemical Co., Milwaukee, Wisconsin). Dissected brain regions were frozen and stored at À80 C until subsequent ACh preparation or total RNA isolation.
ACh Quantification in Brain Tissue
Rationale. Measurement of ACh concentrations in brain tissue for ACh accumulation after AChEI exposure have been successfully determined using a combination of pyrolysis and gas chromatography-mass spectrometry (GC-MS), which involves long sample preparations and labor intensive derivatization of ACh (Hong et al., 2013; Stavinoha et al., 1976) . To improve sample preparation time and maintain accuracy, liquid chromatography methods have been suggested, but due to the polar nature of ACh and other neurotransmitters alike, reversed phase chromatography exhibits poor retention of these neurotransmitters and can only be used on derivatized samples (Tufi et al., 2015) . Cation-exchange or ion-pair chromatography stationary phases would improve ACh retention but use highly concentrated buffers, resulting in electrospray ionization suppression. To avoid retention and suppression limitations, HILIC coupled with mass spectrometry and multiple reaction monitoring has been the emergent and advantageous LC-MS method for neurotransmitter detection and quantitation in biological samples (Peng et al., 2011; Schebb et al., 2008; Uutela et al., 2005; Zhang et al., 2016) . HILIC-MS/MS has several advantages over orthogonal ACh quantitative approaches, such as simple and rapid sample preparation and analysis, especially in complex biological matrices, and the ability to differentiate between ACh and the endogenous ACh isomer (iso-ACh), (3-carboxypropyl)trimethylammonium, which is involved in L-carnitine synthesis (Schebb et al., 2008; Zhang et al., 2016) . These factors make HILIC-MS/MS an advantageous method for ACh determinations in a variety of biological samples, such as blood (Zhang et al., 2016) , cerebrospinal fluid (Zhang et al., 2011) , brain microdialysates (Uutela et al., 2005; Zhang et al., 2007) , cell culture (Schebb et al., 2008) , liver tissue (Wang et al., 2008) , and rodent whole brain homogenate (Peng et al., 2011) .
Preparation of stock solutions. ACh and ACh-d4 (internal standard; I.S.) were prepared by dissolving between 10 and 25 mg (accurately weighed) in 1 ml water. Stock solutions of ACh and AChd4 were prepared by dilution with acetonitrile (ACN) containing 0.1% formic acid and stored at 4 C for no longer than 2 weeks to ensure stability. Fresh standard dilutions were prepared daily. For calibration curve preparation, ACh stock solution was diluted with ACN containing 10.1 nM I.S. (ACh-d4) and 0.1% formic acid, to a final ACh concentration of 5 lM. The remaining standard solutions were diluted with ACN containing 10 nM I.S. The concentrations used for the calibration curve were: 100, 50, 25, 10, 5, 1, and 0.5 nM ACh containing 10 nM ACh-d4. Standards were filtered using Corning regenerated cellulose (RC) filters, with pore size 0.2 lm and 4 mm diameter (Fisher 09-754-3).
Sample preparation. For quantification of ACh, frozen tissue was weighed, diluted with 500-1000 ll ACN with 0.1% formic acid, and sonicated for 90 s (Kontes micro-ultrasonic cell disruptor, Vineland, New Jersey). Sonication in high percent ACN destroys the cell membrane to release ACh and denature proteins. Samples were then centrifuged and ACh-containing supernatant was stored at À20 C until analyses. On the day of analysis, sample supernatants were diluted 1:50 in ACN containing 0.1% formic acid and 10.2 nM ACh-d4 (for a final I.S. concentration of 10 nM in 1 ml). After vortexing for 10 s, samples were filtered using Corning RC filters, with pore size 0.2-lm and 4-mm diameter (Fisher 09-754-3). Samples with ACh < 0.5 nM samples were diluted 1:10 and reanalyzed.
Ultraperformance liquid chromatography-mass spectrometry. For ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) analyses, an Acquity H-class UPLC system (Waters Corp., Milford, Massachusetts) equipped with a cooled autosampler, and a CORTECS UPLC HILIC column (Waters 186007105) with dimensions 2.1 Â 75 mm, particle size 1.6 mm, and pore size 90 Å was used. The UPLC was connected to a Xevo TQD triple quadrupole mass spectrometer (Waters Corp). The software used for controlling the UPLC and MS was MassLynx and TargetLynx V4.1. For UPLC separation, the mobile phase used was 100 mM ammonium formate (A) and acetonitrile (B), both containing 0.1% formic acid. All mobile phase solutions were filtered and degassed prior to use. The elution gradient was as follows: 0 min (90% B), 0.75 min (60% B) 1.00 min (60% B), 1.25 min (30% B), 1.90 min (30% B), 2.20 min (90% B), and 2.50 min (90%B). The target retention time for ACh and ACh-d4 was 1.41 min and 1.40 min, respectively. The gradient steps after 2.20 min were used to clean and re-equilibrate the column. Total analysis time was 3 min, which includes column equilibration. The injection volume was 10 ll, the flow rate was 0.5 ml/min, and the autosampler was kept below 6 C. For MS/MS data acquisition, the blanks, standards, and analytes were ionized using electrospray ionization in positive mode. The ionization parameters for the Xevo TQD MS were as follows: capillary voltage 3 kV, source temperature 150 C and desolvation temperature 500 C. The analytes of interest, ACh and ACh-d4 (I.S.), were detected using positive ion mode tandem mass spectrometry in multiple reaction monitoring mode (MRM). The MRM transitions measured for ACh were 146!87, 59 and for ACh-d4 (I.S.) were 150!91, 109. For both ACh and ACh-d4 the first transition was used for quantification due to peak intensity and the second was used for identification. The optimized UPLC and MS conditions for ACh and ACh-d4 are summarized in Figure 1 . Quantification was based on peak area of the ACh and ACh-d4 peaks. The calibration curve was prepared from the calculated response of the daily prepared standards using the equation
, where A ACh is the peak area of the ACh peak at 1.4 min (146!87), I.S. conc is the concentration of the internal standard (ACh-d4), and A I.S. is the peak area of the I.S. peak at 1.4 min (150!91). With the calculated ACh standard responses, linear regression using 1/x weighting was used as the calibration curve to interpolate the sample ACh. The interassay coefficient of variation (CV) for ACh was <8%, including QC brain samples ran up to a year apart, and intra-assay CV was <3%.
RNA Isolation, cDNA Synthesis, and qPCR The neuroinflammatory RNA markers were determined for STR as described previously for CTX and HIP (Locker et al., 2017) . Briefly, total RNA in the STR was isolated using Trizol reagent (Thermo Fisher Scientific, Waltham, Massachusetts) and Phaselock heavy gel (Eppendorf, AG Hamburg, Germany), and purified with RNeasy mini-spin columns (Qiagen, Valencia, California). STR total RNA was reverse transcribed to cDNA using Superscript III and oligo (dT)12-18 primers (Thermo Fisher Scientific). Real-time PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH, endogenous control), tumor necrosis factoralpha (TNFa), interleukin 6 (IL-6), C-C chemokine ligand 2 (CCL2), interleukin 1beta (IL-1b), leukemia inhibitor factor (LIF), and oncostatin M (OSM) was performed using an Applied Biosystems 7500 real-time PCR system (Thermo Fisher Scientific) in combination with TaqMan chemistry. For PCR amplification, 40 cycles were performed in 50 ml (total volume), of which contained 1 ml cDNA, 2.5 ml of primer/probe mix, and 25 ml of Taqman Universal master mix (Thermo Fisher Scientific). Results from our sequence detection software (version 1.7; Applied Biosystems/Thermo Fisher Scientific) were exported into Excel for relative gene expression analysis. Relative gene expression was determined using the comparative threshold (DDCT) method. Fold changes in mRNA expression were calculated after normalization to GAPDH. The resulting normalized ratio values are expressed as fold changes over corresponding controls.
Statistical Analysis
ACh calibration curves, as described in UPLC-MS/MS methods, were constructed and samples interpolated in GraphPad Prism V5 (San Diego, California). Fold change for mRNA using the DDCT method was calculated in Excel and values were exported to GraphPad Prism V5 for further analysis and graph preparation. Bivariate Pearson correlation analysis between ACh concentrations and -DDCT (not log transformed) mRNA in STR was performed using SAS JMP V13 (Cary, North Carolina). Statistical significance for ACh and mRNA expression was determined using 2-way analysis of variance (ANOVA) with Bonferroni posttest. The 2-way ANOVAs conducted on mRNA were performed on log transformed mRNA data. For all statistical analyses, a difference of p < .05 was considered statistically significant. ACh is reported as nmol/g tissue mean 6 SEM. For mRNA fold change data, error bars reflect SEM.
RESULTS

Focused Microwave Irradiation and HILIC-UPLC-MS/MS Provide a Simple and Rapid Method for ACh Quantitation
The HILIC-UPLC-MS/MS method developed for this study offers a simple, reproducible, and rapid means of quantifying ACh in a complex matrix (brain homogenate). By using focused microwave irradiation as the method of euthanasia, inactivation of endogenous enzymes occurs almost (<0.9 s) simultaneously, as shown previously (Ikarashi et al., 1984; Kobayashi et al., 1980; Stavinoha et al., 1973) , therefore addition of AChE inhibitors or similar additives, postsacrifice during sample preparation is unnecessary. Additionally, rapid sample preparation via high percentage acetonitrile and ultrasonic homogenization makes this method advantageous over other ACh methods. Total analysis times for HILIC-UPLC-MS/MS were 3 min per sample, making this method high-throughput. Elution of ACh occurred at 1.41 min and was effectively separated from iso-ACh, which eluted at 1.69 min (Figure 1 ). The percent coefficient of variation reported in this study was <3% and 8% for intra-and interassay variation, respectively. The vehicle only control mice ACh values for all experiments (n ¼ 15) were: CTX (12.1 6 2.8 nmol/g tissue), HIP (19.1 6 4.1 nmol/g tissue), and STR (42.5 6 5.3 nmol/g tissue). These control values are similar to those obtained using focused microwave irradiation and orthogonal ACh quantification methods (Kobayashi et al., 1980) .
CORT Priming Ameliorates DFP-Induced Effects on ACh and is Brain Region Specific
The body of literature categorizing GWI as a protracted sickness behavior in conjunction with epidemiology studies suggesting environmental exposures to a host of chemicals, including AChEIs (nerve agents, pesticides, and prophylactics) and concomitant high physiological stress in theater has led to the current rodent model of GWI. Using the exposure paradigm presented previously (Locker et al., 2017) , CORT was administered in the drinking water for 4 days to induce high levels of circulating CORT and on the fifth day, mice were exposed to a single dose of DFP. In this model, we found that DFP significantly reduced AChE activity in whole brain lysates 30 min after exposure, an observation that was significantly ameliorated by prior CORT exposure (Locker et al., 2017) . For the current study, at 30-min post-DFP exposure, mice were sacrificed via focused microwave irradiation and discrete brain regions were dissected for ACh analyses. The 30-min time point was selected from previous time course data (30 min, 2-, and 24-h post-DFP), where 30 min showed the maximum ACh concentration. After the 30-min time point, ACh steadily decreased at 2 h (16% reduction from 30-min post-DFP ACh) and 24 h (40% reduction from 30-min post-DFP ACh). Using HILIC-UPLC-MS/MS, ACh concentrations in CTX, HIP, and STR were determined (Figure 2 ). For HIP and STR, CORT þ DFP ACh responses were significantly reduced (p < .05) when compared with DFP alone ACh concentrations. However, in the CTX, CORT had no effect on DFP-induced increase in ACh.
CORT Priming Does Not Significantly Ameliorate Irreversible AChEI CPO-or Reversible AChEI PHY-Induced Effects on ACh In our prior evaluation of AChE activity, we found that prior CORT exposure significantly reversed the dramatic reduction in enzyme activity levels induced by CPO exposure (Locker et al., 2017) . However, the reversible AChE inhibitor PHY instigated a significant, yet lesser magnitude, reduction in AChE activity that was not responsive to CORT (Locker et al., 2017) . Using the same dosing paradigm as described for DFP, the irreversible inhibitor CPO and reversible inhibitor PHY were studied for ACh effects with and without CORT priming (Figure 3) . In HIP and STR at 30-min postexposure to CPO, ACh was significantly increased but CORT priming had no ACh amelioration effects. At 30-min postexposure to PHY, there were no significant differences in CTX, HIP, or STR (data not shown). To determine if this was an exposure time-related effect, mice were sacrificed at 45-min postexposure to PHY. At 45-min postexposure to PHY, all brain regions measured for ACh (CTX, HIP, and STR) were significantly increased, but similarly to CPO, CORT priming had no statistically significant effect on AChEI-induced ACh accumulation (Figure 3) . The use of 45-min post-PHY exposure to measure brain ACh accumulation is consistent with previous research using microdialysates of mice exposed to PHY, where the ACh accumulation maxima occurs at 45-min postexposure (Mohr et al., 2013) .
CORT Priming Exacerbates Neuroinflammatory Response in STR to
Irreversible AChEIs DFP and CPO In keeping with our previous analyses (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015) , to determine the contribution of ACh levels to the neuroinflammatory response after irreversible AChEI exposure, a panel of neuroinflammation-related cytokines and chemokines were measured at 6-h post-AChEI exposure. This time point was used due to acute response maxima across most neuroinflammatory markers for the AChEIs used in this study (O'Callaghan et al., 2015) . The panel of neuroinflammation-related cytokines and chemokines used in this study were TNFa, IL-6, CCL2, IL-1b, LIF, and OSM. After DFP or CPO-alone exposure, the neuroinflammatory panel responses were minimal. For DFP-alone, IL-6 was the only marker measured to have a statistically significant increase in fold change (Figure 4 ). For CPO-alone, IL-6 was significantly decreased and OSM was significantly increased at 6-h postexposure ( Figure 5 ). However, for CORT þ DFP and CORT þ CPO, all neuroinflammatory responses were significantly exacerbated when compared with AChEI alone (Figs. 4 and 5) . The only exception is OSM, where CPO alone and CORT þ CPO were significantly increased over their respective controls, but were not significantly different from each other, indicating a lack of CORT priming effect on OSM. Bivariate Pearson correlation analysis for STR ACh and measured STR neuroinflammatory responses shows no significant relationship between ACh and cytokine and chemokine mRNA for DFP and CPO, with the exception of a moderate positive correlation for CPO STR ACh and CCL2 (r ¼ 0.573, p ¼ .0103) and OSM (r ¼ 0.533, p ¼ .0189). These trends for cytokine and chemokine responses were similar to those found previously for CTX and HIP (Locker et al., 2017) .
Reversible AChEI PHY Has Little Impact on Neuroinflammatory Response in STR Alone or in Combination With CORT To determine the contribution of ACh levels to the neuroinflammatory response after a reversible AChEI exposure; the same panel of neuroinflammation-related cytokines and chemokines were measured at 6-h post-PHY exposure. For the neuroinflammatory panel chosen in this study, the reversible AChEI PHY had no significant differences from control for PHY-alone groups. Additionally, for CORT þ PHY, only TNFa and OSM responses were significantly different from PHY alone, albeit minimally in comparison to the exacerbated responses for CORT þ DFP and CORT þ CPO; results similar to what was observed previously in CTX and HIP (Locker et al., 2017) . Bivariate Pearson correlation analysis also showed no statistically Figure 2 . ACh in discrete brain regions after DFP exposure. ACh was measured using our HILIC-UPLC-MS/MS method as described in Materials and Methods. Mice were exposed to control or CORT (400 mg/l in 1.2% EtOH) in the drinking water for 4 days. On the fifth day, mice were exposed to a single i.p. injection of saline or DFP (4 mg/ kg) and sacrificed via focused microwave irradiation 30-min postexposure. Whole brain samples were free-hand dissected for CTX, HIP, and STR. Significance was determined using two-way ANOVA with Bonferroni post-test, where * indicates p < .05 for vehicle vs DFP or CORT vs CORTþDFP and # indicates p < .05 DFP alone vs CORTþDFP. Data are represented as mean 6 SEM and n ¼ 5.
significant correlation between PHY, STR, Ach, and STR mRNA responses for this mouse model of GWI paradigm.
DISCUSSION
Although more than a quarter of a century removed from the GW, a complete understanding of the exposure(s) initiating GWI or viable treatments thereof have yet to be determined (Dursa et al., 2016) . It has been suggested that AChEI exposure in theater, such as airborne nerve agents and pesticides, insecticides sprayed on uniforms, and nerve agent prophylactics, were involved in the initiation of GWI (Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015; RAC, 2014; Steele, 2000; White et al., 2016) . With these exposures in mind, we included DFP, which is a surrogate for the nerve agent sarin, CPO, which is the oxon and active metabolite of CPF, and PHY, which is a surrogate for PB that is capable of crossing the blood brain barrier (Grauer et al., 2000; Locker et al., 2017) , with or without prior exposure to CORT as a physiological stress mimic for testing our GWI model. Here, we found that while exposure to irreversible AChEIs increase the amount of ACh in the brain, prior exposure to CORT abrogates this increase for DFP, an effect not seen with CPO or PHY (Figs. 2  and 3) . Furthermore, as STR showed the strongest ACh response, we measured cytokine mRNA expression in this region to further investigate the relationship between AChE and neuroinflammation. In accordance with our previous findings (Locker et al., 2017; O'Callaghan et al., 2015) , CORT pretreatment resulted in a significant neuroinflammatory response to DFP and CPO, but not PHY exposure in STR (Figs. 4-6) .
The analysis of discrete brain regions prevents the dilution of potential measured effects in whole brain, thus reducing the chance that important changes after xenobiotic exposure go undetected (Gupta, 2004) . The heterogeneity of brain regions is especially important to consider for elucidating mechanisms and toxicological endpoints related to AChEI exposure. For example, STR has a higher density of choline acetyltransferase (ChAT), AChE, and ACh concentration than CTX or HIP, as well as the highest rate of ACh accumulation and AChE activity (Gupta, 2004; Stavinoha et al., 1976; Won et al., 2001) . ChAT and AChE enzymes have exceedingly fast kinetics and rapid ACh turnover (Bertrand et al., 1994; Jenden et al., 1974; Kobayashi et al., 1980; Stavinoha et al., 1973; Wilson and Harrison, 1961) , thus the time needed to dissect after sacrifice, even if it is mere minutes, can significantly alter the resulting analyses. We have shown previously that phosphorylation state, which also has exceedingly fast kinetics (ie, phosphatase and protease enzymes), can be rapidly altered postsacrifice if using live decapitation or other forms of euthanasia that are not focusedmicrowave irradiation (O'Callaghan and Sriram, 2004) . These sample degradation limitations can be overcome by using focused microwave irradiation as the mode of rodent sacrifice, enzyme inactivation and sacrifice occur almost simultaneously (<0.9 s), thereby preserving in vivo ACh (Ikarashi et al., 1984; Kobayashi et al., 1980; Stavinoha et al., 1973) . In one study, the ACh concentration in whole mouse brain doubled by utilization of focused microwave irradiation instead of euthanasia via decapitation and immediate homogenization alone (Stavinoha et al., 1973) . Therefore, focused microwave irradiation for euthanasia allows for the time necessary for discrete brain region dissection without rapid degeneration of the sample. In this study, our control (vehicle only) ACh results for CTX, HIP, and STR were consistent with control mouse ACh levels found in the literature that also used focused microwave irradiation for euthanasia (Kobayashi et al., 1980) .
To disentangle the potential association of AChEI-induced accumulation of ACh in discrete brain regions and GWI, we utilized a method that is capable of not only preserving in vivo ACh levels postsacrifice, but also rapidly quantifying brain ACh. The HILIC-UPLC-MS/MS method developed for this study offers a simple sample preparation protocol and high-throughput means of quantifying ACh in a complex sample matrix. The Figure 3 . ACh in discrete brain regions after A, irreversible AChEI CPO or B, reversible AChEI PHY exposure. ACh was measured using our HILIC-UPLC-MS/MS method as described in Materials and Methods. Mice were exposed to control or CORT (400 mg/l in 1.2% EtOH) in the drinking water for 4 days. On the fifth day, mice were exposed to a single i.p. injection of peanut oil (for CPO controls), saline (for PHY controls), CPO (8 mg/kg), or PHY (0.5 mg/kg) and sacrificed via focused microwave irradiation 30-min post-CPO and 45-min post-PHY. Whole brain samples were free-hand dissected for CTX, HIP, and STR. Significance was determined using 2-way ANOVA with Bonferroni post-test, where * indicates p < .05 for vehicle versus AChEI or CORT versus CORT þ AChEI and # indicates p < .05 AChEI alone versus CORT þ AChEI.
Data are represented as mean 6 SEM and n ¼ 5.
percent coefficient of variation reported in this study was <3% and 8% for intra-and interassay variation, respectively. These values are consistent with previous studies using HILIC-UPLC-MS/MS to measure ACh in peripheral blood mononuclear cells (Zhang et al., 2016) . Additionally, the rapid catalysis of AChE requires a method that is capable of inactivating AChE almost simultaneously at the time of sacrifice to report accurate in vivo ACh concentrations. Without this method of euthanasia, the time to sacrifice and dissect can greatly affect the measured ACh during analyses. ACh concentrations observed in this study were consistent with those found in previous DFP exposure studies using orthogonal techniques to measure ACh, such as pyrolysis or ACh derivatization prior to GC-MS, after euthanasia via focused microwave irradiation (Flynn and Wecker, 1986; Russell et al., 1981) . Previously, ACh levels in rat STR (150 nmol/ g) and HIP (40 nmol/g) 1-h post-DFP exposure have been reported (Flynn and Wecker, 1986) . Similarly, in mice, a previous study has reported ACh in CTX (20 nmol/g) and HIP (25 nmol/g) 24-h postexposure to DFP alone. These brain-region specific responses to DFP suggested that it would be advantageous to measure discrete brain regions for ACh accumulation to describe our mouse model of GWI. In our study, at 30-min postexposure to DFP alone in mice, ACh levels were 34.2 6 3.6 nmol/ g in CTX, 28.0 6 1.2 nmol/g in HIP, and 82.8 6 5.5 nmol/g in STR, consistent with those found in the literature (Russell et al., 1981) . The development of this rapid and reproducible method allows for ACh levels after AChEI exposure to be quantified and compared for further investigation into the acute response in our GWI model.
Although all 3 AChEIs used in this study are potent AChE inhibitors and used as GW-relevant chemical exposures, it has been shown that not all organophosphate compounds induce toxicity by the same mechanisms (Pope, 1999) . Additionally, the potency of AChEIs may not necessarily correlate to acute toxicity in vivo (Chambers, 1992) . The potential for these AChEIs (DFP, CPO, and PHY) to have divergent mechanisms of toxicity or neuroinflammation and their relevance to in theater exposures makes their inclusion in our mouse model of GWI advantageous. In this study, for our CORT þ DFP model, we found an amelioration of AChE inhibition by CORT priming, as evidenced Figure 4 . qPCR of measured neuroinflammatory cytokines and chemokines in STR after DFP exposure. Mice were exposed to control or CORT (400 mg/l in 1.2% EtOH) in the drinking water for 4 days. On the fifth day, mice were exposed to a single i.p. injection of saline (DFP vehicle control) or DFP (4 mg/kg) and sacrificed via decapitation 6-h post-DFP. Data were analyzed using the DDCT method. Significance was determined using 2-way ANOVA with Bonferroni post-test where * indicates p < .05 for vehicle versus DFP or CORT versus CORT þ DFP and # indicates p < .05 vehicle versus CORT or DFP alone versus CORT þ DFP. Data are expressed as mean fold change 6 SEM and n ¼ 5.
by a decrease in ACh compared with DFP alone, that is brain region specific. By using this established mouse model of GWI, we found that concomitant stress and DFP exposure (CORT þ DFP) portends mixture-driven effects in HIP and STR, whereas CORT priming did not affect AChE inhibition in CTX. Additionally, this unique CORT primed ACh response cannot be extended to all coexposures with GW-relevant AChEIs, whereby CORT þ CPO and CORT þ PHY did not significantly ameliorate the effects of the AChEIs alone in the HIP and STR. Previously, we have shown at 30 min post-AChEI exposure, AChE specific activity in whole brain is significantly reduced for DFP (10% AChE activity of vehicle control), CPO (25% AChE activity of vehicle control), and PHY (40% AChE activity of vehicle control) alone groups (Locker et al., 2017) . However, when primed with CORT, AChE activity is significantly increased over AChEI alone for DFP (50% of vehicle control) and CPO (50% of vehicle control), but not PHY (45% of vehicle control, where PHY alone was 40% of vehicle control) (Locker et al., 2017) . These results are similar to our ACh data, where CORT priming dramatically affects and blunts the DFPinduced inhibition of AChE. Additionally, others have shown that swim stress does not affect PHY-induced inhibition of whole brain or CTX cholinesterase (Grauer et al., 2000) , supporting our CORT primed PHY ACh results. By dissecting discrete brain regions instead of using whole brain, the regions most affected by CORT priming can be determined and may guide further research on elucidating the potential mechanisms of GWI etiology.
The similarity in symptomatology of sickness behavior and GWI suggests an underlying neuroinflammatory role in GWI etiology (Dantzer and Kelley, 2007; Konsman et al., 2002; Koo et al., 2018; Locker et al., 2017; O'Callaghan et al., 2015; Steele, 2000) . The exact mechanism and relationship between identified GWrelevant exposures that may have initiated GWI, such as nerve agent, pesticide, and nerve agent prophylactic AChEIs in addition to concomitant high physiological stress, and neuroinflammation has yet to be elucidated. By quantifying ACh in discrete brain regions, such as STR, HIP, and CTX, the association of ACh levels and relevant neuroinflammatory biomarkers can be determined. Across all AChEIs used in this study, the STR is the most responsive to AChE inhibition; however, ACh levels varied Figure 5 . qPCR of measured neuroinflammatory cytokines and chemokines in STR after CPO exposure. Mice were exposed to control or CORT (400 mg/l in 1.2% EtOH) in the drinking water for 4 days. On the fifth day, mice were exposed to a single i.p. injection of peanut oil (CPO vehicle control) or CPO (8 mg/kg) and sacrificed via decapitation 6-h post-CPO. Data were analyzed using the DDCT method. Significance was determined using 2-way ANOVA with Bonferroni post-test where * indicates p < .05 for vehicle versus CPO or CORT versus CORT þ CPO and # indicates p < .05 vehicle versus CORT or CPO alone versus CORT þ CPO. Data are expressed as mean fold change 6 SEM and n ¼ 5.
amongst the AChEIs when primed with CORT. These disparate responses warranted further investigation of the STR and underlying neuroinflammatory signatures. When using the nerve agent sarin surrogate DFP, or CPO, the irreversible AChEIs alone did not significantly affect the neuroinflammatory panel used in this study. However, when DFP or CPO-exposed mice were primed with CORT, almost all of the neuroinflammatory biomarker responses measured were significantly exacerbated (Figs 4 and 5) . Although these dramatic neuroinflammatory responses in our GWI mouse model using CORT þ DFP and CORT þ CPO were significant, there was no significant association between the STR cytokines or chemokines and STR ACh levels, which was verified statistically with bivariate Pearson correlation analysis, with the exception of CPO STR ACh and CPO STR CCL2 and OSM. Although STR CCL2 and ACh were moderately correlated for CPO, it is important to note that CORT þ CPO CCL2 is significantly increased (fold change 52.4 6 13.6) compared with CPO alone (fold change 15.6 6 6.6), but there is no significant difference between CPO ACh (80.1 6 3.0 nmol/g) and CORT þ CPO ACh (66.7 6 8.4 nmol/g). This lack of association between STR ACh levels and neuroinflammatory biomarkers used in this study suggest that the exacerbated neuroinflammatory response to CORT primed DFP or CPO exposure in our model of GWI may be driven by AChE-independent mechanisms, such as disruption of critical intracellular signaling pathways related to inflammation. In our previous study, we found a similar exacerbated neuroinflammatory signature in the CTX and HIP for DFP and CPO (Locker et al., 2017; O'Callaghan et al., 2015) . Although these results do not indicate a significant link between ACh levels and neuroinflammation in our model of GWI, they do provide evidence for using discrete brain regions instead of whole brain for both ACh and neuroinflammatory biomarkers when evaluating potential etiological mechanisms of GWI.
To determine if a GW-relevant reversible AChEI exhibits the same neuroinflammatory effects as the irreversible AChEIs DFP and CPO, we used PHY, which is considered a surrogate for the nerve agent oral prophylactic, PB, capable of crossing the blood brain barrier (Grauer et al., 2000) . PB has been previously identified in epidemiological studies as a potential exposure related Figure 6 . qPCR of measured neuroinflammatory cytokines and chemokines in STR after PHY exposure. Mice were exposed to control or CORT (400 mg/l in 1.2% EtOH) in the drinking water for 4 days. On the fifth day, mice were exposed to a single i.p. injection of saline (PHY vehicle control) or PHY (0.5 mg/kg) and sacrificed via decapitation 6-h post-PHY. Data were analyzed using the DDCT method. Significance was determined using 2-way ANOVA with Bonferroni post-test where * indicates p < .05 for vehicle versus PHY or CORT versus CORT þ PHY and # indicates p < .05 vehicle versus CORT or PHY alone versus CORT þ PHY. Data are expressed as mean fold change 6 SEM. and n ¼ 5.
to GWI (Golomb, 2008; Steele et al., 2011) . However, it has been shown that PB does not cross the blood brain barrier, even during times of stress, which can increase permeability of the blood brain barrier (Grauer et al., 2000) . By using PHY in this study, we can determine the effects of a GW-relevant reversible AChEI. In the neuroinflammatory panel used for this study, PHY alone did not significantly affect the measured cytokine or chemokine responses 6-h postexposure in the STR, whereas ACh levels at 45-min postexposure were significantly increased for PHY and CORT þ PHY. This similar neuroinflammatory signature was determined previously for PHY and CORT primed PHY responses in CTX and HIP (Locker et al., 2017) . Additionally, there was no significant relationship between ACh levels and the neuroinflammatory biomarkers for any of the brain regions used in this study for PHY. Neuroinflammatory profiles for DFP-and CPOexposed mice follow a similar pattern, with an exacerbated mixture response with CORT, whereas the reversible AChEI PHY showed little to no effect. From this data, DFP and CPO are more advantageous for a mouse model of GWI than PHY.
In conclusion, we have developed a rapid, simple, and reproducible method for measuring ACh in discrete brain regions following AChEI exposure. By including this method in our mouse model of GWI, brain region-specific effects driving the GWI phenotype can be elucidated. Specifically, we found that amelioration of ACh accumulation via CORT priming is unique to DFP exposed mice in HIP and STR, whereas CORT priming had little to no effect on CPO-or PHY-induced ACh accumulation in the same brain areas. Despite these disparate ACh levels, CORT priming with the irreversible AChEIs DFP and CPO elicited an exacerbated neuroinflammatory response in comparison to AChEI-alone exposure, but PHY did not significantly affect the neuroinflammatory response alone or when combined with CORT. This exacerbated neuroinflammatory response and amelioration of AChEI-induced ACh accumulation to CORT priming and irreversible AChEI exposure further validates this GWI model. In light of these findings, discrete brain region analysis and the inclusion of exogenous CORT to account for concomitant high physiological stress are vital to GWI model development and analyses. Additionally, the disassociation of ACh and neuroinflammatory biomarkers used in this study suggests that GWI may be due to brain region-specific off-target or secondary mechanisms of AChEI exposure and not AChE inhibition. Toxic effects due to non-AChE targets of AChEI exposure have been suggested previously (Bushnell et al., 1993; Pope et al., 1992; Ray and Richards, 2001; van Dongen and Wolthuis, 1989) . Organophosphate exposures have been shown to interact with other biomolecular targets via phosphorylation of nucleophilic serine residues (O'Neill, 1981) , DNA methylation (Mehl et al., 1994) , or disruption of neuropeptide metabolism (Kubek et al., 1997; Richards et al., 2000) . Further research investigating GWrelevant exposures and their potential non-AChE targets and corresponding effects must be performed to elucidate the underlying mechanism(s) of GWI etiology.
